[HTML][HTML] Type I and II interferons in the anti-tumor immune response

SE Fenton, D Saleiro, LC Platanias - Cancers, 2021 - mdpi.com
Simple Summary Interferons are cytokines that play key roles in the activation of cellular
components of the immune response, such as dendritic cells, macrophages and T cells …

[HTML][HTML] Harnessing innate immune pathways for therapeutic advancement in cancer

A Hu, L Sun, H Lin, Y Liao, H Yang… - Signal Transduction and …, 2024 - nature.com
The innate immune pathway is receiving increasing attention in cancer therapy. This
pathway is ubiquitous across various cell types, not only in innate immune cells but also in …

Type 1 conventional dendritic cells and interferons are required for spontaneous CD4+ and CD8+ T‐cell protective responses to breast cancer

R Mattiuz, C Brousse, M Ambrosini… - Clinical & …, 2021 - Wiley Online Library
Objectives To better understand how immune responses may be harnessed against breast
cancer, we investigated which immune cell types and signalling pathways are required for …

[HTML][HTML] DNA barcoding reveals ongoing immunoediting of clonal cancer populations during metastatic progression and immunotherapy response

LA Baldwin, N Bartonicek, J Yang, SZ Wu… - Nature …, 2022 - nature.com
Cancers evade the immune system through the process of cancer immunoediting. While
immune checkpoint inhibitors are effective for reactivating tumour immunity in some cancer …

Therapeutic strategies to remodel immunologically cold tumors

M Wang, S Wang, J Desai, JA Trapani… - Clinical & …, 2020 - Wiley Online Library
Immune checkpoint inhibitors (ICIs) induce a durable response in a wide range of tumor
types, but only a minority of patients outside these 'responsive'tumor types respond, with …

[HTML][HTML] Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics

T Akinsipe, R Mohamedelhassan, A Akinpelu… - Frontiers in …, 2024 - frontiersin.org
The breast cancer tumor microenvironment (TME) is dynamic, with various immune and non-
immune cells interacting to regulate tumor progression and anti-tumor immunity. It is now …

Small extracellular vesicle‐derived miR‐574‐5p regulates PGE2‐biosynthesis via TLR7/8 in lung cancer

J Donzelli, E Proestler, A Riedel… - Journal of …, 2021 - Wiley Online Library
Intercellular communication plays an essential role in lung cancer (LC). One of the major
players in cell‐cell‐communication is small extracellular vesicles (sEV). SEV trigger various …

[HTML][HTML] Roles of protein disulfide isomerase in breast cancer

S Yang, C Jackson, E Karapetyan, P Dutta, D Kermah… - Cancers, 2022 - mdpi.com
Simple Summary Triple-negative breast cancer (TNBC) is the most aggressive subtype of
breast cancer and has a poor prognosis and higher recurrence rate due to ineffective …

Novel immune targets for the treatment of triple-negative breast cancer

C Corti, E Nicolò, G Curigliano - Expert Opinion on Therapeutic …, 2021 - Taylor & Francis
Introduction To overcome mechanisms of primary and secondary resistance to the anti-
tumor immune response, novel targets such as ICOS, LAG3, and TIM3 are currently being …

Breast cancer immune microenvironment: from pre-clinical models to clinical therapies

BE Wilson, C Gorrini, DW Cescon - Breast Cancer Research and …, 2022 - Springer
The breast cancer tumour microenvironment (BC-TME) is characterized by significant
cellular and spatial heterogeneity that has important clinical implications and can affect …